0001437749-14-009039.txt : 20140514
0001437749-14-009039.hdr.sgml : 20140514
20140514154408
ACCESSION NUMBER: 0001437749-14-009039
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140513
FILED AS OF DATE: 20140514
DATE AS OF CHANGE: 20140514
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPAX LABORATORIES INC
CENTRAL INDEX KEY: 0001003642
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 650403311
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
BUSINESS PHONE: 510-240-6000
MAIL ADDRESS:
STREET 1: 30831 HUNTWOOD AVENUE
CITY: HAYWARD
STATE: CA
ZIP: 94544
FORMER COMPANY:
FORMER CONFORMED NAME: GLOBAL PHARMACEUTICAL CORP \DE\
DATE OF NAME CHANGE: 19951117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TERRERI PETER R
CENTRAL INDEX KEY: 0001238456
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34263
FILM NUMBER: 14841317
MAIL ADDRESS:
STREET 1: 1351 BRYANT COURT
CITY: AMBLER
STATE: PA
ZIP: 19002
4
1
rdgdoc.xml
FORM 4
X0306
4
2014-05-13
0001003642
IMPAX LABORATORIES INC
IPXL
0001238456
TERRERI PETER R
C/O IMPAX LABORATORIES, INC.
30831 HUNTWOOD AVENUE
HAYWARD
CA
94544
1
Common Stock
2014-05-13
4
S
0
666
26.70
D
41336
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Mark A. Schlossberg, by Power of Attorney
2014-05-14